Health-Related Quality of Life Among Patients with Postmenopausal Osteoporosis Treated with Weekly and Monthly Bisphosphonates

被引:12
作者
Kastelan, Darko [1 ]
Vlak, Tonko [2 ]
Lozo, Petar [3 ]
Gradiser, Marina [4 ]
Mijic, Sime [5 ]
Nikolic, Tatjana [6 ]
Miskic, Blazenka [7 ]
Car, Dolores [6 ]
Tajsic, Gordana [6 ]
Dusek, Tina [1 ]
Jajic, Zrinka [8 ]
Grubisic, Frane [8 ]
Poljicanin, Tamara [9 ]
Bakula, Miro [10 ]
Dzubur, Fedja [1 ]
Strizak-Ujevic, Matilda [11 ]
Kadojic, Mira [12 ]
Radman, Maja [13 ]
Vugrinec, Maja [14 ]
Kuster, Zeljka [14 ]
Pekez, Marijeta [14 ]
Radovic, Endi [15 ]
Labar, Ljubica [16 ]
Crncevic-Orlic, Zeljka [17 ]
Korsic, Mirko [1 ]
机构
[1] Univ Hosp Zagreb, Dept Endocrinol, Zagreb 10000, Croatia
[2] Univ Hosp Split, Dept Rehabil Med & Rheumatol, Split, Croatia
[3] Outpatient Clin Gynaecol Lozo, Zadar, Croatia
[4] Cty Hosp Cakovec, Dept Internal Med, Cakovec, Croatia
[5] Hlth Med Ctr Phys Med & Rehabil, Jastrebarsko, Croatia
[6] Univ Clin Traumatol, Zagreb, Croatia
[7] Dr Josip Bencevic Gen Hosp, Dept Internal Med, Slavonski Brod, Croatia
[8] Univ Hosp Sestre Milosrdnice, Dept Rheumatol Phys Med & Rehabil, Zagreb, Croatia
[9] Vuk Vrhovac Univ Clin Diabet Endocrinol & Metab D, Zagreb, Croatia
[10] Gen Hosp Sv Duh, Dept Endocrinol Diabet & Metab Disorders, Zagreb, Croatia
[11] Gen Hosp Sibenik, Shibenik, Croatia
[12] Univ Hosp Osijek, Dept Phys Med & Rehabil, Osijek, Croatia
[13] Univ Hosp Split, Dept Diabet Endocrinol & Metab, Split, Croatia
[14] Univ Zagreb, Sch Med, Zagreb 41001, Croatia
[15] Univ Hosp Rijeka, Dept Phys & Rehabil Med, Rijeka, Croatia
[16] Special Hosp Orthopaed, Biograd, Croatia
[17] Univ Hosp Rijeka, Dept Endocrinol, Rijeka, Croatia
关键词
Bisphosphonates; Osteoporosis; Quality of life; EQ-5D; OPTQoL; MONTHLY ORAL IBANDRONATE; ONCE-MONTHLY IBANDRONATE; BONE-MINERAL DENSITY; VERTEBRAL FRACTURES; WEEKLY ALENDRONATE; OPEN-LABEL; WOMEN; RISEDRONATE; THERAPY; TRIAL;
D O I
10.3109/07435800.2010.505218
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Objective. The present study was designed to assess the effect of monthly ibandronate on health-related quality of life (HR-QoL) in patients with postmenopausal osteoporosis previously treated with weekly bisphosphonates. Methods. HR-QoL was assessed by Euroqol (EQ-5D) and Osteoporosis Targeted Quality of Life (OPTQoL) questionnaires. Results. The EQ-5D questionnaire showed significant improvement associated with ibandronate treatment, occurring in mobility (p < 0.01), usual activity (p < 0.01), pain/discomfort (p < 0.05), and anxiety/depression (p < 0.05). In addition, ibandronate treatment considerably improved patients' perceived health on a visual analog scale (p < 0.001). For the OPTQoL questionnaire, patients reported less physical difficulty (p < 0.001), fewer adaptations in their lives (p < 0.001), and less fear (p < 0.001) with ibandronate than with weekly bisphosphonates. Conclusion. The study demonstrated that patients who were transferred from weekly bisphosphonates to a monthly ibandronate experienced improved HR-QoL.</.
引用
收藏
页码:165 / 173
页数:9
相关论文
共 26 条
[1]
Patient Satisfaction in Postmenopausal Women Treated with a Weekly Bisphosphonate Transitioned to Once-Monthly Ibandronate [J].
Bonnick, Sydney Lou ;
Silverman, Stuart ;
Tanner, S. Bobo ;
Martens, Mark ;
Bachmann, Gloria ;
Kohles, Joseph D. ;
Civitelli, Roberto .
JOURNAL OF WOMENS HEALTH, 2009, 18 (07) :935-943
[2]
Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis [J].
Chesnut, CH ;
Skag, A ;
Christiansen, C ;
Recker, R ;
Stakkestad, JA ;
Hoiseth, A ;
Felsenberg, D ;
Huss, H ;
Gilbride, J ;
Schimmer, RC ;
Delmas, PD .
JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 (08) :1241-1249
[3]
QUALITY-OF-LIFE ISSUES IN WOMEN WITH VERTEBRAL FRACTURES DUE TO OSTEOPOROSIS [J].
COOK, DJ ;
GUYATT, GH ;
ADACHI, JD ;
CLIFTON, J ;
GRIFFITH, LE ;
EPSTEIN, RS ;
JUNIPER, EF .
ARTHRITIS AND RHEUMATISM, 1993, 36 (06) :750-756
[4]
Adherence to monthly and weekly oral bisphosphonates in women with osteoporosis [J].
Cotte, F. -E. ;
Fardellone, P. ;
Mercier, F. ;
Gaudin, A. -F. ;
Roux, C. .
OSTEOPOROSIS INTERNATIONAL, 2010, 21 (01) :145-155
[5]
Derman R, 2009, CLIN INTERV AGING, V4, P357
[6]
Patient preference for once-monthly ibandronate versus once-weekly alendronate in a randomized, open-label, cross-over trial: the Boniva Alendronate Trial in Osteoporosis (BALTO) [J].
Emkey, R ;
Koltun, W ;
Beusterien, K ;
Seidman, L ;
Kivitz, A ;
Devas, V ;
Masanauskaite, D .
CURRENT MEDICAL RESEARCH AND OPINION, 2005, 21 (12) :1895-1903
[7]
Efficacy and Tolerability of Once-Monthly Oral Ibandronate (150 mg) and Once-Weekly Oral Alendronate (70 mg): Additional Results From the Monthly Oral Therapy With Ibandronate for Osteoporosis Intervention (MOTION) Study [J].
Emkey, Ronald ;
Delmas, Pierre D. ;
Bolognese, Michael ;
Borges, Lindolfo C. ;
Cosman, Felicia ;
Ragi-Eis, Sergio ;
Recknor, Christopher ;
Zerbini, Cristiano A. ;
Neate, Colin ;
Sedarati, Farhad ;
Epstein, Solomon .
CLINICAL THERAPEUTICS, 2009, 31 (04) :751-761
[8]
Quality of life in women with postmenopausal osteoporosis: Correlation between QUALEFFO 41 and SF-36 [J].
Ferreira, Neville de Oliveira ;
Arthuso, Michael ;
da Silva, Raimunda ;
Pedro, Adriana Orcesi ;
Pinto Neto, Aarao Mendes ;
Costa-Paiva, Lucia .
MATURITAS, 2009, 62 (01) :85-90
[9]
Treatment preference for monthly oral ibandronate and weekly oral alendronate in women with postmenopausal osteoporosis: A randomized, crossover study (BALTO II) [J].
Hadji, Peyman ;
Minne, Helmut ;
Pfeifer, Michael ;
Bourgeois, Pierre ;
Fardellone, Patrice ;
Licata, Angelo ;
Devas, Vipul ;
Masanauskaite, Daiva ;
Barrett-Connor, Elizabeth .
JOINT BONE SPINE, 2008, 75 (03) :303-310
[10]
Risk of fracture in women treated with monthly oral ibandronate or weekly bisphosphonates: The eValuation of IBandronate Efficacy (VIBE) database fracture study [J].
Harris, S. T. ;
Reginster, J. -Y. ;
Harley, C. ;
Blumentals, W. A. ;
Poston, S. A. ;
Barr, C. E. ;
Silverman, S. L. .
BONE, 2009, 44 (05) :758-765